Finance

Beta
Lists
ELTX:NASDAQ
Elicio Therapeutics Inc
$4.20
+1.57%
(+0.065) 1D
Jun 23, 1:11:43 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELTX...
Open
$4.09
High
$4.40
Low
$3.97
Mkt. cap
80.16M
Avg. vol.
2.56M
Volume
1.14M
52-wk high
$16.00
52-wk low
$2.66
EPS
-$2.41
Beta
1.13
Shares outstanding
19.09M
No. of employees
33
Open
$4.09
High
$4.40
Low
$3.97
Mkt. cap
80.16M
Avg. vol.
2.56M
Volume
1.14M
52-wk high
$16.00
52-wk low
$2.66
EPS
-$2.41
Beta
1.13
Shares outstanding
19.09M
No. of employees
33
News stories
From sources across the web
About Elicio Therapeutics Inc
CEO-
Employees33
Founded2011
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websiteelicio.com
Analyst Ratings
Based on 4 analysts giving stock ratings to ELTX in the past 3 months
Strong Buy
Buy
3
Hold
1
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ELTX in the last 3 months.
Highest
Current $4.20
$27.00 (+542.09%)
Average
$20.67 (+391.56%)
Lowest
$12.00 (+185.37%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Robert Burns
H.C. Wainwright
Buy
Reiterated
$23.00
+447%
06/22/2026
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Initiated
$12.00
+185.4%
06/18/2026
Boris Peaker
JonesTrading
Hold
Downgraded
-
-
06/15/2026
Mayank Mamtani
B. Riley Securities
Buy
Initiated
$27.00
+542.1%
06/10/2026
Aydin Huseynov
Ladenburg Thalmann & Co.
Buy
Initiated
$20.00
+375.6%
04/15/2026
Soumit Roy
JonesTrading
Buy
Maintained
$18.00
+328.1%
04/06/2026
Michael King
Rodman & Renshaw
Buy
Initiated
$17.00
+304.3%
03/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7.01M
5.04M
5.08M
6.76M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.08M
3.01M
3.76M
3.84M
Operating expense
10.09M
8.04M
8.84M
10.60M
Total operating expenses
10.09M
8.04M
8.84M
10.60M
Operating income
-10.09M
-8.04M
-8.84M
-10.60M
Other non operating income
-859.00K
-1.81M
1.26M
-984.00K
EBT including unusual items
-10.56M
-10.08M
-7.72M
-11.82M
EBT excluding unusual items
-10.98M
-10.08M
-7.72M
-11.82M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10.56M
-10.08M
-7.72M
-11.82M
Net profit margin
-
-
-
-
Earnings per share
-0.66
-0.60
-0.49
-0.65
Interest and investment income
168.00K
199.00K
199.00K
157.00K
Interest expense
-194.00K
-426.00K
-337.00K
-407.00K
Net interest expenses
-26.00K
-227.00K
-138.00K
-250.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.04M
-8.00M
-8.79M
-10.56M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer